ResMed Inc. (RMD) exhibits 59.4% gross margins and 22.9% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 19.9x enterprise multiple and 6.7% implied options volatility.
Sustained 59.4% gross profitability converts into 32.7% operating margin and 22.9% ROIC, outpacing sector cost of capital.
ROIC: 22.9% // GM: 59.4%YoY revenue trajectory of +9.8% paired with 4.67% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +9.8% // FCF YLD: 4.67%Altman Z-Score of 12.49 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 12.49 // F-SCORE: 9/9Trading at 25.4x trailing P/E (23.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 25.4x // EV/EBITDA: 19.9xOptions market prices a ±6.7% implied move with a 0.78 put/call ratio around $248.00 max pain.
IMPL MOVE: ±6.7% // P/C: 0.78Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 27.2% net margins.
NET MARGIN: 27.2% // D/E: 0.15x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for RMD & activate live FRED threshold breach alerts.